Table 3.
Subgroup comparisons among surveyed patients receiving pharmacist-guided point-of-care COVID-19 testing and counseling
| Parameter | All surveyed patients, n = 622 | COVID(+) n = 108 (17.4) | Age ≥ 65 y n = 66 (10.6) | Female n = 319 (51.2) | Hispanic n = 398 (64.0) |
|---|---|---|---|---|---|
| COVID(+) | 108 (17.4) | 108 (100)a | 4 (6.1)a | 63 (19.7) | 91 (22.9)a |
| Q1. I felt comfortable going to a community pharmacy to receive testing for COVID-19 infection. – SA/A | 618 (99.4) | 107 (99.1) | 65 (98.5) | 317 (99.4) | 397 (99.7) |
| Q2. Having a testing center at a community pharmacy improved my access to health care services. – SA/A | 607 (97.6) | 105 (97.2) | 63 (95.5) | 310 (97.2) | 388 (97.5) |
| Q3. After my conversation with the pharmacist, I felt more knowledgeable about managing coronavirus signs and symptoms. – SA/A | 560 (90.0) | 100 (92.6) | 54 (81.8)a | 283 (88.7) | 375 (94.2)a |
| Q4. After my conversation with the pharmacist, I felt more knowledgeable about knowing when to seek medical attention for potential COVID-19 symptoms. – SA/A | 548 (88.1) | 100 (92.6) | 51 (77.3)a | 278 (87.1) | 368 (92.5)a |
| Q5. My test results were reported to me in a timely manner. – SA/A | 606 (97.4) | 104 (96.3) | 62 (93.9) | 310 (97.2) | 388 (97.5) |
| Q6. Pharmacist-provided testing services benefit my community. – SA/A | 611 (98.2) | 108 (100) | 63 (95.5) | 311 (97.5) | 393 (98.7) |
| Q7. Overall, I am satisfied with the testing services I received. – SA/A | 617 (99.2) | 107 (99.1) | 64 (97.0) | 316 (99.1) | 396 (99.5) |
| Q8. I would be willing to receive a pharmacist-provided test for COVID-19 infection at a community pharmacy again. – SA/A | 609 (97.9) | 103 (95.4) | 64 (97.0) | 311 (97.5) | 391 (98.2) |
Abbreviations used: A, agree; COVID-19, coronavirus disease; Q, question; SA, strongly agree.
Note: Values are given as n (%).
a
Statistically significant difference (P < 0.05) compared with all surveyed patients.